AstraZeneca
British-Swedish pharmaceutical company
Products
Subsidiaries
Common Themes
Videos Mentioning AstraZeneca
A Postmortem on My Response to Covid (Episode #335)
Sam Harris
One of the vaccine manufacturers mentioned, with its vaccine noted for having potential complications.
#129 - Tom Dayspring, M.D.: The latest insights into cardiovascular disease and lipidology
Peter Attia MD
Pharmaceutical company that acquired Epanova, a free omega-3 fatty acid combination of EPA and DHA, whose trial was stopped due to futility.
Ep. 216: Boosting Creative Insight With Deep Walks
Cal Newport
Company that implemented a rule to make it harder for employees to reply-all to more than 25 recipients.
#160 - Paul Offit, MD: Latest on COVID-19 vaccines and their safety, herd immunity, & viral variants
Peter Attia MD
Mentioned as a partner with the Jenner Institute for an adenovirus vector vaccine.
#24 – Tom Dayspring, M.D., FACP, FNLA – Part V of V: Lp(a), inflammation, oxLDL, remnants, and more
Peter Attia MD
The company that owns Repatha, and was hoping for a combo product with their EPA formulation.
Caffeinated Naps, Intuitive Eating, and Q&A Catch-Up (Episode 57)
Stronger By Science
Pharmaceutical company that developed one of the COVID-19 vaccines, currently on hold in some places.
#83 – Bill Harris, Ph.D.: Omega-3 fatty acids
Peter Attia MD
The pharmaceutical company manufacturing Epanova, the drug used in the STRENGTH trial.
337- Insulin resistance masterclass: The full body impact of metabolic dysfunction, treatment & more
Peter Attia MD
Pharmaceutical company that collaborated with Dr. DeFronzo and Bristol-Myers Squibb in the development of dapagliflozin (Farxiga).
E113: DOJ tries to break up Google, vaccine questions, Ukraine escalation & more
All-In Podcast
A pharmaceutical company whose COVID-19 vaccine was among the 'more regular ones' that were 'dumped on developing countries' by Western nations.
🔬There Is No AlphaFold for Materials — AI for Materials Discovery with Heather Kulik
Latent Space
A pharmaceutical company where John Paul Jana is an assistant director running their inverse design program.